Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Speak Life Science appears to be a very small, private communications and public relations business serving the life sciences sector rather than a drug developer, biotech platform company, or therapeutic manufacturer. Public business-directory records identify it as Speak Life Science, LLC in Byfield, Massachusetts, founded around 2015, with Amy Speak listed as owner or principal. Available evidence suggests the business focused on media, communications, and related support for life science clients. There is no reliable evidence of an internal therapeutic pipeline, proprietary drug platform, clinical-stage assets, or regulated manufacturing operations. Multiple directory listings indicate the business may now be inactive or permanently closed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Speak Life Science.